Citation Impact

Citing Papers

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
2009 Standout
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
2021 StandoutNobel
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
2017 StandoutNobel
Focus on lymphangiogenesis in tumor metastasis
2005
Modified uridines are the key to a successful message
2021 StandoutNobel
Lipid nanoparticles for mRNA delivery
2021 Standout
Roles of individual prolyl‐4‐hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: insights from genetically modified mice
2012 StandoutNobel
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
mRNA-Based Protein Replacement Therapy for the Heart
2018
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
Phase 1 LymfactinⓇ Study: Short-term Safety of Combined Adenoviral VEGF-C and Lymph Node Transfer Treatment for Upper Extremity Lymphedema
2020
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
Ranibizumab for Neovascular Age-Related Macular Degeneration
2006 Standout
Increased Erythropoiesis in Mice Injected With Submicrogram Quantities of Pseudouridine-containing mRNA Encoding Erythropoietin
2012 StandoutNobel
Hypoxia-inducible factor 1-induced G protein-coupled receptor 35 expression is an early marker of progressive cardiac remodelling
2013
New insights into nNOS regulation of vascular homeostasis
2005 StandoutNobel
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
2006 Standout
Perspectives and opportunities for nanomedicine in the management of atherosclerosis
2011
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
The biology of VEGF and its receptors
2003 Standout
VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study
2015
Angiogenesis in health and disease
2003 Standout
Placenta-directed gene therapy for fetal growth restriction
2017
Sustained Release of Multiple Growth Factors from Injectable Polymeric System as a Novel Therapeutic Approach Towards Angiogenesis
2009
Lymphangiogenesis in development and human disease
2005 StandoutNature
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
VEGF receptor signalling ? in control of vascular function
2006 Standout
Restenosis following implantation of bare metal coronary stents: Pathophysiology and pathways involved in the vascular response to injury
2006
Alginate: Properties and biomedical applications
2011 Standout
Angiogenesis in life, disease and medicine
2005 StandoutNature
VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment
2004 Standout
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
2015 Standout
Gene transfer as a tool to induce therapeutic vascular growth
2003
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Vascular Growth in Ischemic Limbs: A Review of Mechanisms and Possible Therapeutic Stimulation
2008
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
2004 Standout
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
2011 StandoutNature
EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection
2016 StandoutNobel
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
2015 StandoutNobel
Maternal uterine artery VEGF gene therapy for treatment of intrauterine growth restriction
2017
Epigenetic mechanisms in diabetic vascular complications
2011
Angiogenesis as a therapeutic target
2005 StandoutNature
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?
2008
Adenovirus-Mediated Gene Transfer of Human Vascular Endothelial Growth Factor-D Induces Transient Angiogenic Effects in Mouse Hind Limb Muscle
2007
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
2022 StandoutNobel
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
Nutrition and Aberrant DNA Methylation Patterns in Atherosclerosis: More than Just Hyperhomocysteinemia? ,
2005
Angiogenesis
2005
Nanoparticulate carriers for the treatment of coronary restenosis.
2007
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
VEGF and its receptors
2004
Growth Factor Therapy and Autologous Lymph Node Transfer in Lymphedema
2011
Vascular Endothelial Growth Factor D Is Dispensable for Development of the Lymphatic System
2005
Polydopamine and Its Derivative Materials: Synthesis and Promising Applications in Energy, Environmental, and Biomedical Fields
2014 Standout
Stromal Cell–Derived Factor-1α and CXCR4 Expression in Hemangioblastoma and Clear Cell-Renal Cell Carcinoma: von Hippel-Lindau Loss-of-Function Induces Expression of a Ligand and Its Receptor
2005 StandoutNobel
Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1
2003 StandoutNobel
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
2011 Standout
Mechanisms of Diabetic Complications
2013 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
2023 StandoutNobel
Aging and Atherosclerosis
2012
VEGF-D Is the Strongest Angiogenic and Lymphangiogenic Effector Among VEGFs Delivered Into Skeletal Muscle via Adenoviruses
2003
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Short Hairpin RNA Interference Therapy for Ischemic Heart Disease
2008

Works of Marja Hedman being referenced

Synthetic mRNA Encoding VEGF-A in Patients Undergoing Coronary Artery Bypass Grafting: Design of a Phase 2a Clinical Trial
2020
10-year safety follow-up in patients with local VEGF gene transfer to ischemic lower limb
2011
Progress and prospects: hurdles to cardiovascular gene therapy clinical trials
2011
The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice
2009
Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer
2009
Increased Vascularity Detected by Digital Subtraction Angiography after VEGF Gene Transfer to Human Lower Limb Artery: A Randomized, Placebo-Controlled, Double-Blinded Phase II Study
2002
Angiogenic Responses of Vascular Endothelial Growth Factors in Periadventitial Tissue
2003
Adenoviral Catheter-Mediated Intramyocardial Gene Transfer Using the Mature Form of Vascular Endothelial Growth Factor-D Induces Transmural Angiogenesis in Porcine Heart
2004
Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia
2003
DNA hypomethylation and methyltransferase expression in atherosclerotic lesions
2002
Rankless by CCL
2026